# DESCRIPTION

- acknowledge government support

## TECHNICAL FIELD OF THE INVENTION

- define technical field

## BACKGROUND OF THE INVENTION

- describe glioma characteristics
- discuss limitations of current diagnosis
- motivate need for better cancer characterization

## SUMMARY OF THE INVENTION

- summarize invention aspects

## DETAILED DESCRIPTION OF THE INVENTION

- introduce glioma subtypes and their diagnosis
- describe polymerase chain reactions (PCR) for determining glioma subtype
- outline techniques for determining mutation status at TERT promoter hotspots and IDH1/IDH2 hotspots
- describe use of solid supports to capture relevant polynucleotides for testing
- discuss design of probes and primers for hybridization and detection
- introduce kits for packaging components for carrying out processes
- describe grouping patients based on prognosis and genetic signatures
- analyze association between TERT promoter and IDH1/2 mutations in glioma
- describe genetic signatures of three common glioma subtypes
- discuss stratification of patients into reproducible subgroups based on survival
- analyze association between TERT promoter/IDH1/2 mutational status and OS
- discuss use of genetic signatures to refine diagnosis and inform clinicians
- summarize findings and their implications for glioma diagnosis and treatment

### EXAMPLE 1

- describe sample collection, processing, and sequencing
- outline statistical methods used in the study

### EXAMPLE 2

- describe prevalence and prognostic impact of TERT promoter mutations

### EXAMPLE 3

- describe co-occurring mutations in TERT promoter and IDH1/2

### EXAMPLE 4

- describe association between TERT promoter and IDH1/2 mutations and OS
- analyze tumor distributions and OS among Grade II gliomas
- analyze tumor distributions and OS among Grade III gliomas
- analyze tumor distributions and OS among Grade IV gliomas

